17-41725036-C-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_177977.3(HAP1):c.1525G>T(p.Val509Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000323 in 1,612,378 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V509M) has been classified as Uncertain significance.
Frequency
Consequence
NM_177977.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152144Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000478 AC: 12AN: 251036 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1460116Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 726456 show subpopulations
GnomAD4 genome AF: 0.000243 AC: 37AN: 152262Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74444 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1525G>T (p.V509L) alteration is located in exon 11 (coding exon 11) of the HAP1 gene. This alteration results from a G to T substitution at nucleotide position 1525, causing the valine (V) at amino acid position 509 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at